seach-icon
  • user-img

    QONEQT in News

    14-Nov-2022 05:06 AM


    thumbnail

    Aurobindo Pharma's Second Quarter Net Profit Falls 41% To Rs 409 Crore

    The shares of the pharmaceutical company closed at Rs 488 apiece on Friday on BSE.
    Aurobindo Pharma has posted a decline of 41 per cent in its net profit to Rs 409 crore in the quarter ended September against Rs 697 crore in the year-ago period.
    Aurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy said the company's second quarter performance was subdued, mainly due to macro-environment factors and higher competitive intensity for some products in the US, according to a statement shared with stock exchanges on Saturday.
    The CMD said the company's continued focus on biosimilars, research and development, innovation and increasing manufacturing capacity will enhance its product offerings in various markets.
    Source: NDTV
    #AurobindoPharma